Literature DB >> 11777553

HLA class II associated risk and protection against multiple sclerosis-a Finnish family study.

Mikko Laaksonen1, Tomi Pastinen, Minna Sjöroos, Satu Kuokkanen, Juhani Ruutiainen, Marja Liisa Sumelahti, Helena Reijonen, Reijo Salonen, Juhani Wikström, Martin Panelius, Jukka Partanen, Pentti J Tienari, Jorma Ilonen.   

Abstract

We analyzed the HLA class II haplotypes in 249 Finnish nuclear families and compared the frequencies of parental haplotypes transmitted or non-transmitted to multiple sclerosis (MS) patients. The most important predisposing haplotype was DRB1*15-DQB1*0602 (P<10(-6)) as expected and a weak predisposing effect of DRB1*04-DQB1*0302 was revealed after the elimination of DRB1*15-DQB1*0602. HLA-DRB1*01-DQB1*0501 and DRB1*13-DQB1*0603 were negatively associated with MS in transmission disequilibrium test, but only the DRB1*13-DQB1*0603 association remained significant (P=0.008) after the elimination of DRB1*15-DQB1*0602 haplotypes. Based on this study HLA class II haplotypes exhibit both predisposing and protective effects in MS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11777553     DOI: 10.1016/s0165-5728(01)00456-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  18 in total

1.  -to: Pani MA, Van Autreve J, Van Der Auwera BJ, Gorus FK, Badenhoop K (2002) Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type I diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules. Diabetologia 45:1340-1343.

Authors:  R Hermann; R Veijola; I Sipilä; M Knip; H K Akerblom; O Simell; J Ilonen
Journal:  Diabetologia       Date:  2003-04-09       Impact factor: 10.122

2.  Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure?

Authors:  R Hermann; M Knip; R Veijola; O Simell; A-P Laine; H K Akerblom; P-H Groop; C Forsblom; K Pettersson-Fernholm; J Ilonen
Journal:  Diabetologia       Date:  2003-03-18       Impact factor: 10.122

3.  HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.

Authors:  S Laivoranta-Nyman; T Möttönen; R Hermann; J Tuokko; R Luukkainen; M Hakala; P Hannonen; M Korpela; U Yli-Kerttula; A Toivanen; J Ilonen
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

4.  Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.

Authors:  Bryan A Bassig; Peter D Inskip; Laurie Burdette; William R Shapiro; Robert G Selker; Howard A Fine; Jay S Loeffler; Peter M Black; Robert Dubrow; Alina V Brenner
Journal:  J Neuroimmunol       Date:  2010-12-30       Impact factor: 3.478

5.  The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children.

Authors:  C-O Jonson; M Hedman; M Karlsson Faresjö; R Casas; J Ilonen; J Ludvigsson; O Vaarala
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

6.  Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.

Authors:  Sophia S Wang; Amr M Abdou; Lindsay M Morton; Rasmi Thomas; James R Cerhan; Xiaojiang Gao; Wendy Cozen; Nathaniel Rothman; Scott Davis; Richard K Severson; Leslie Bernstein; Patricia Hartge; Mary Carrington
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

7.  Reduced CCR4, interleukin-13 and GATA-3 up-regulation in response to type 2 cytokines of cord blood T lymphocytes in infants at genetic risk of type 1 diabetes.

Authors:  Kristiina Luopajärvi; Susanne Skarsvik; Jorma Ilonen; Hans K Akerblom; Outi Vaarala
Journal:  Immunology       Date:  2007-01-18       Impact factor: 7.397

Review 8.  The immunogenetics of multiple sclerosis: A comprehensive review.

Authors:  Jill A Hollenbach; Jorge R Oksenberg
Journal:  J Autoimmun       Date:  2015-07-02       Impact factor: 7.094

9.  Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma.

Authors:  Chenan Zhang; Adam J de Smith; Ivan V Smirnov; John K Wiencke; Joseph L Wiemels; John S Witte; Kyle M Walsh
Journal:  J Neurooncol       Date:  2017-07-18       Impact factor: 4.130

10.  Humoral beta-cell autoimmunity is rare in patients with the congenital rubella syndrome.

Authors:  H Viskari; J Paronen; P Keskinen; S Simell; B Zawilinska; I Zgorniak-Nowosielska; S Korhonen; J Ilonen; O Simell; A-M Haapala; M Knip; H Hyöty
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.